XenoGesis reports third year of Export Growth

Nottingham-based Contract Research Organisation (CRO) XenoGesis has reported a third year of export growth with one third of its revenue now coming from overseas. Founded in 2011, XenoGesis now has clients across six continents and has experienced consistent growth since day one. The increase in international clients is the direct...

LLEP Board Members appointed to May 2020

The LLEP has re-appointed four board members to serve a second three year term: Andrew Cliffe, Managing Director, East Midlands Airport, Jaspal Singh Minhas, Managing Director, Electrical Design & MFG Co Ltd, Sharon Redrobe, CEO, Twycross Zoo and Kevin Harris, Vice-Chair of the LLEP. Kevin Harris, Vice-Chair of the LLEP, said: “I...

Two Nottinghamshire Companies awarded at Medilink East Midlands Innovation Day

Two Nottinghamshire businesses have been selected as winners at the prestigious Medilink East Midlands Business awards 2017; NuVision Biotherapies Ltd, based at MediCity, and Promethean Particles, based at Genesis Park. NuVision Biotherapies was established in 2015 as a spin out company of The University of Nottingham. It is developing ground-breaking...

Derbyshire-based Ayva Pharma takes home Medilink East Midlands Business Award

Derbyshire company Ayva Pharma, based at Hilton Business Park has been selected as a Medilink East Midlands Business Awards winner for 2017. Ayva Pharma is a leading international pharmaceutical company which supplies medicines to hospitals, organisations and governments across the globe. Specialising in supplying to the Middle East and North...

Ex-pharma Vice President appointed to key national health role

A former Vice President of AstraZeneca has been appointed to a key national health role - less than a year after joining the NHS. Professor Mike Hannay is to take up the position of Vice Chair of the national AHSN Network, a collaboration of England’s 15 Academic Health Science Networks...

Quotient Clinical appoints Azhar Kalim as Chief Commercial Officer

Quotient Clinical (“Quotient”), the drug development services provider, today announced the appointment of Azhar Kalim as Chief Commercial Officer (CCO). Azhar will lead the enhanced commercial team in a new role, with a focus on supporting Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions....

LCCC continue great partnership with Morningside Pharmaceuticals Ltd

Leicestershire County Cricket Club are thrilled to announce the continuation of our partnership with Morningside Pharmaceuticals Ltd. Dr Nik Kotecha, Chief Executive Officer (CEO) of Morningside Pharmaceuticals Ltd, has been a big supporter of the club over the last few years. Morningside  sponsor the Medical Centre in the lower Meet,...

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​